- Gentlemen, start your drones: Judge’s ruling opens door for commercial use
- Soldier who hid, bragged about not saluting flag to be punished — in secret
- ‘Maverick’ of the seas: ‘Top Gun’ school for U.S. ship officers to launch
- Putin declares Sochi Paralympics open amid Ukrainian protest
- ‘In Jesus name, we pray’ sparks ire at Ohio council meeting
- Navy’s first laser weapon ready for prime time; drone killer to deploy this summer
- Billionaire backer: Rick Santorum ‘needs to be heard’ in 2016
- Obamacare fallout: 49 percent pessimistic; 45 percent ‘scared’
- DHS accused of holding U.S. citizen at airport, using emails to pry into her sex life
- Seattle socialist: Minimum-wage discussion skewed by ‘right-wing’ GAO analysis
Formerly barred student attends his prom
SHELTON — A Connecticut teen who was briefly barred from prom for his over-the-top invitation to his date finally got to go.
Shelton High School senior James Tate attended the prom Saturday, nearly a month after he was prohibited for posting his invitation to Sonali Rodrigues in 12-inch-high cardboard letters on the school wall.
School officials had said his invitation was a safety risk and suspended him for a day and barred him from the prom. Headmaster Beth Smith later reversed the decision, acknowledging the international attention the case received.
Dressed in a three-piece black tuxedo with a purple flower in his jacket pocket, Mr. Tate arrived at a pre-prom photo event followed by television cameras. Miss Rodrigues, dressed in a lavender prom dress, said he was funny and “pretty cute.”
Mom from '16 and Pregnant' accused of drug crimes
Authorities say 37-year-old April Michelle Purvis was arrested Sunday morning during a road check in Floyd County. Ms. Purvis is charged with felony possession of methamphetamine and misdemeanor possession of marijuana.
Ms. Purvis and her daughter, Whitney, were featured in the first season of the popular reality show about teenage pregnancy. A passenger in her car was charged with misdemeanor marijuana possession.
Two melanoma drugs show promise in studies
CHICAGO — Two new drugs using very different scientific approaches can extend survival among patients with the deadliest form of skin cancer, offering the first new hope for real progress in many years.
Advanced melanoma patients taking an experimental pill, vemurafenib, developed by Roche and Daiichi Sankyo were 63 percent less likely to die than patients given chemotherapy, according to a new trial presented Sunday at a meeting of the American Society of Clinical Oncology in Chicago.
Dr. Paul Chapman of Memorial Sloan-Kettering Cancer Center in New York and the study’s lead investigator called the results an “unprecedented level of difference” for patients with advanced melanoma, who typically survive just eight months on current treatments.
TWT Video Picks
Taxpayers must pay the freight for over-budget train projects
- Kim Jong-un calls for execution of 33 Christians
- Rand Paul wins 2014 CPAC straw poll, Ted Cruz finishes a distant second
- Senate Democrats, Republicans spar over restoring unemployment benefits
- 80 people publicly executed across North Korea for films, Bibles
- Bill Clinton poses for photo with Bunny Ranch prostitutes
- CURL: The modern GOP really is Reagan's 'Big Tent' party
- U.S. pilot scares off Iranians with 'Top Gun'-worthy stunt: 'You really ought to go home'
- Six Senate seats could hinge on Keystone pipeline
- Russias Putin nominated for Nobel Peace Prize
- CPAC 2014: Straw poll signals Paul-Cruz showdown
Pope Francis meets his 'mini-me'
Celebrity deaths in 2014
Winter storm hits states — again